INNOVATE Corp. (VATE)
NYSE: VATE · Real-Time Price · USD
6.00
+0.32 (5.63%)
Apr 1, 2026, 9:57 AM EDT - Market open
INNOVATE Revenue
In the year 2025, INNOVATE had annual revenue of $1.25B with 12.55% growth. INNOVATE had revenue of $382.70M in the quarter ending December 31, 2025, with 61.75% growth.
Revenue (ttm)
$1.25B
Revenue Growth
+12.55%
P/S Ratio
0.06
Revenue / Employee
$394,179
Employees
3,161
Market Cap
81.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.25B | 138.90M | 12.55% |
| Dec 31, 2024 | 1.11B | -315.90M | -22.20% |
| Dec 31, 2023 | 1.42B | -214.30M | -13.09% |
| Dec 31, 2022 | 1.64B | 432.10M | 35.85% |
| Dec 31, 2021 | 1.21B | 488.30M | 68.11% |
| Dec 31, 2020 | 716.90M | -1.44B | -66.71% |
| Dec 31, 2019 | 2.15B | -26.00M | -1.19% |
| Dec 31, 2018 | 2.18B | -937.30M | -30.07% |
| Dec 31, 2017 | 3.12B | 142.80M | 4.80% |
| Dec 31, 2016 | 2.97B | 2.77B | 1,365.79% |
| Dec 31, 2015 | 202.88M | 115.32M | 131.71% |
| Dec 31, 2014 | 87.56M | -143.13M | -62.04% |
| Dec 31, 2013 | 230.69M | -72.27M | -23.86% |
| Dec 31, 2012 | 302.96M | -109.02M | -26.46% |
| Dec 31, 2011 | 411.98M | 129.97M | 46.08% |
| Dec 31, 2010 | 282.02M | -550.82M | -66.14% |
| Dec 31, 2008 | 832.84M | -63.19M | -7.05% |
| Dec 31, 2007 | 896.03M | -97.01M | -9.77% |
| Dec 31, 2006 | 993.03M | -174.98M | -14.98% |
| Dec 31, 2005 | 1.17B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Southland Holdings | 772.17M |
| Shimmick | 492.84M |
| Energy Services of America | 424.47M |
| Blink Charging Co. | 106.63M |
| OneConstruction Group | 52.23M |
| Reitar Logtech Holdings | 48.61M |
| Skyline Builders Group Holding | 46.01M |
| DirectBooking Technology | 15.14M |
VATE News
- 1 day ago - MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation - GlobeNewsWire
- 5 days ago - INNOVATE Corp. (VATE) Q4 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 5 days ago - INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 15 days ago - INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th - GlobeNewsWire
- 7 weeks ago - Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN) - GlobeNewsWire
- 2 months ago - INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend - GlobeNewsWire
- 3 months ago - MediBeacon® Next Generation TGFR™ System Receives FDA Approval - GlobeNewsWire
- 4 months ago - INNOVATE Corp. (VATE) Q3 2025 Earnings Call Transcript - Seeking Alpha